Localization of RANKL (receptor activator of NFκB ligand) mRNA and protein in skeletal and extraskeletal tissues

• Published in: Bone (New York, N.Y.) N.Y.), 1999-11, Vol.25 (5), p.525-534
• Main Authors: Kartsogiannis, V, Zhou, H, Horwood, N.J, Thomas, R.J, Hards, D.K, Quinn, J.M.W, Niforas, P, Ng, K.W, Martin, T.J, Gillespie, M.T
• Format: Article
• Language: English
• Subjects: Amino Acid Sequence; Animals; Biological and medical sciences; Bone and Bones - embryology; Bone and Bones - metabolism; Bone Development - physiology; Bone Marrow - metabolism; Carrier Proteins - biosynthesis; Carrier Proteins - genetics; Endochondral bone; Female; Fundamental and applied biological sciences. Psychology; Giant Cell Tumor of Bone - pathology; Giant Cells - metabolism; Giant Cells - pathology; Humans; Immunohistochemistry; In Situ Hybridization; Intramembranous bone; Male; Membrane Glycoproteins - biosynthesis; Membrane Glycoproteins - genetics; Mice; Mice, Inbred C57BL; Molecular Sequence Data; ODF; Organ Specificity - genetics; Osteoblasts - metabolism; Osteoclasts - cytology; Osteoclasts - metabolism; Pregnancy; Rabbits; RANK Ligand; Receptor Activator of Nuclear Factor-kappa B; RNA, Messenger - biosynthesis; RNA, Messenger - metabolism; Skeleton and joints; Species Specificity; TRANCE; Vertebrates: osteoarticular system, musculoskeletal system
• ISSN: 8756-3282; 1873-2763
• DOI: 10.1016/S8756-3282(99)00214-8

RANKL (receptor activator of NFκB ligand) is a membrane-associated osteoblastic molecule, and along with macrophage-colony-stimulating factor, is crucial for osteoclast formation. RANKL is known to be strongly expressed in osteoblasts and lymphoid tissues. We have sought to determine the skeletal and extraskeletal sites of production of RANKL mRNA and protein using the techniques of in situ hybridization and immunohistochemistry. Expression of RANKL mRNA and protein were determined in the developmental progression of endochondral bone formation in mouse, intramembranous bone formation in a rabbit model (mRNA only), in human giant cell tumors of bone, and at extraskeletal sites in the mouse. RANKL mRNA was expressed in prehypertrophic and hypertrophic chondrocytes at day E15 embryonic mouse long bone, and its expression was maintained at these sites throughout development. In newborn and adult mice, high levels of RANKL mRNA were expressed in mesenchymal cells of the periosteum and in mature osteoblasts, while megakaryocytes within the marrow microenvironment expressed RANKL mRNA from 1 week of age. Immunohistochemical analysis revealed a similar localization pattern of RANKL protein at the sites described. In the intramembranous bone formation model, RANKL mRNA was expressed in mesenchymal cells and in actively synthesizing osteoblasts, but not in flattened lining osteoblasts or late osteocytes. Expression of RANKL mRNA and protein in osteoclasts was variable with those within resorption lacunae showing the strongest signal/staining. Likewise, expression varied in osteoclasts from giant cell tumor of bone with a minority of tartrate-resistant acid phosphatase-positive multinucleated cells having no detectable RANKL mRNA or protein. In extraskeletal tissues, RANKL mRNA and protein were detected in the brain, heart, kidney, skeletal muscle, and skin throughout mouse development, suggesting the possibility of several other functions of the molecule. RANKL was also developmentally regulated, as evidenced by its expression in the intestine, liver, and lung at E15 and newborn mouse but not in the adult.